Concourse Financial Group Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Concourse Financial Group Securities’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,643	Closed	-$572K	–	2128
2020 Q1	$478K	Buy	+3,643	New	+$519K	0.05%	259
2019 Q2	–	Sell	-3,026	Closed	-$418K	–	2295
2019 Q1	$456K	Buy	3,026 +413	+16%	+$59.4K	0.05%	286
2018 Q4	$324K	Buy	2,613 +1,668	+177%	+$228K	0.04%	325
2018 Q3	$150K	Buy	+945	New	+$143K	0.04%	334

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Concourse Financial Group Securities's FBT Position: Q2 2020 in Review

Concourse Financial Group Securities sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2020, closing a stake of 3,643 shares — an estimated $572K sold.

Concourse Financial Group Securities first reported a position in FBT in Q3 2018 and held it in 4 quarters. The position peaked at $478K in Q1 2020. 224 funds tracked by Wall St. Rank hold FBT as of Q2 2020.

Concourse Financial Group Securities reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2020 after selling out during the quarter.
Concourse Financial Group Securities sold 3,643 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2020, an estimated $572K.
Concourse Financial Group Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 4 quarters.
Concourse Financial Group Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $478K in Q1 2020.
224 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2020.

Based on Concourse Financial Group Securities's 13F filing for Q2 2020, filed 13 Aug 2020.